Centiva Capital LP Takes Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Centiva Capital LP acquired a new stake in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 12,669 shares of the company's stock, valued at approximately $266,000.

Several other institutional investors also recently bought and sold shares of PAHC. Barclays PLC grew its stake in shares of Phibro Animal Health by 25.7% during the 3rd quarter. Barclays PLC now owns 143,337 shares of the company's stock worth $3,228,000 after purchasing an additional 29,271 shares during the period. SG Americas Securities LLC grew its stake in shares of Phibro Animal Health by 7.4% during the 4th quarter. SG Americas Securities LLC now owns 13,162 shares of the company's stock worth $276,000 after purchasing an additional 906 shares during the period. Inspire Investing LLC acquired a new position in shares of Phibro Animal Health during the 4th quarter worth $791,000. Smith Group Asset Management LLC acquired a new position in shares of Phibro Animal Health during the 4th quarter worth $541,000. Finally, New York State Teachers Retirement System grew its stake in shares of Phibro Animal Health by 16.7% during the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock worth $114,000 after purchasing an additional 775 shares during the period. 99.34% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

PAHC has been the topic of a number of recent analyst reports. StockNews.com raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday. Morgan Stanley boosted their price objective on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a research report on Thursday, May 8th. Finally, Barclays boosted their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research report on Monday, February 10th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $20.00.

Phibro Animal Health Stock Performance

Shares of PAHC opened at $24.50 on Tuesday. The business's fifty day moving average price is $20.01 and its 200 day moving average price is $21.84. Phibro Animal Health Co. has a 12-month low of $16.16 and a 12-month high of $26.55. The stock has a market capitalization of $992.32 million, a PE ratio of 51.04, a price-to-earnings-growth ratio of 0.45 and a beta of 0.62. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. The firm had revenue of $347.80 million for the quarter, compared to analysts' expectations of $352.41 million. Equities research analysts forecast that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Wednesday, June 4th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.96%. The ex-dividend date of this dividend is Wednesday, June 4th. Phibro Animal Health's payout ratio is 61.54%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.